Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025 bởiMike Ng

Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025
Oral disorders prevalent in patients with diabetes
Oral disorders prevalent in patients with diabetes
09 Oct 2025